Investors

EastGate Biotech Files Application to Initiate Phase III clinical trial for Insugin

June 26, 2019 by admin

Approximately 200 patients will be included in the Phase III study in order to achieve regulatory approval in Pakistan

Read more

Bill Abajian of EastGate Biotech Corp. to speak at the 2019 M&A Forum for Pharma, Biotech and Med Device to be held between August 12 – 14, 2019 in Philadelphia

June 12, 2019 by admin

Forum to focus on Innovative Partnership Opportunities for Product, Porfolio and Market Development

Read more

Link to interview with Ms. Anna Gluskin, CEO, Eastgate Biotech Corp. on Wall Street Analyzer

May 2, 2019 by admin

Link to the interview of Eastgate's CEO Ms. Anna Gluskin.

Read more

EastGate Biotech Announces Positive Phase II Clinical Results of its Innovative Liquid Insulin Mouth Rinse Solution for Type 2 Diabetes

April 24, 2019 by admin

Following a 3-month treatment, significant Hb1c Reduction was observed with administration of a single dose of Insugin two times a day

Read more

Eastgate BioTech Corp (OTCBB: ETBI) Interview with CEO Anna Gluskin

April 10, 2019 by admin

Eastgate BioTech Corp (OTCBB: ETBI) Interview with CEO Anna Gluskin

Read more

https://upticknewswire.com/interview-ceo-anna-gluskin-of-eastgate-biotech-corp-otc-etbi/

March 25, 2019 by admin

Interview: CEO Anna Gluskin of Eastgate Biotech Corp. (OTC: ETBI)

Read more

Eastgate Biotech Signs Strategic Alliance Agreement with MJ Biopharm for Insulin API Supply

March 19, 2019 by admin

Alliance with MJ Biopharm of Mumbai, India positions the company to further its plans for SEA countries for its liquid insulin mouth rinse

Read more

EastGate Biotech Attends Arab Health Conference Seeking Additional Joint Venture Partnerships

January 30, 2019 by admin

EastGate Biotech to Showcase Insulin Products at the Dubai World Trade Centre

Read more

EastGate Biotech Appoints Additional Consultants in Preparation of Progressing Company Developments in 2019

December 19, 2018 by admin

Eastgate Biotech Corp.appointed key consultants Saul A. Mashaal, PhmB, MBA and Munaf Ali, PhD to assist in regulatory matters and manufacturing of the company's liquid insulin mouth rinse solution for Type 2 diabetes and pre-diabetes patients.

Read more
RSS Icon